Aachen papers per year

Papers 116

An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA
2023 HemaSphere article Medicine CAR-T cell therapy research Open access

Kai Rejeski, Raffaella Greco, Francesco Onida, Isabel Sánchez‐Ortega, Chiara Bonini, Anna Sureda, +3 more

59

citations
The New EU Regulation on In Vitro Diagnostic Medical Devices: Implications and Preparatory Actions for Diagnostic Laboratories
2021 HemaSphere article Health Professions Healthcare Regulation Open access cited by 2 patents

Bart R. Lubbers, Anke Schilhabel, Christa M. Cobbaert, David González de Castro, Isabel Dombrink, Monika Brüggemann, +2 more

58

citations
A German multicenter real‐world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma
2025 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

Jan Hendrik Frenking, Christine Riedhammer, Raphael Teipel, Florian C. Bassermann, Britta Besemer, Moritz Bewarder, +26 more

25

citations
Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype
2022 HemaSphere article Medicine Platelet Disorders and Treatments Open access

Ferdows Atiq, Johan Boender, Waander L. van Heerde, Juan M. Tellez Garcia, Selene C. M. Schoormans, Sandy Krouwel, +9 more

25

citations
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
2023 HemaSphere article Medicine Histiocytic Disorders and Treatments Open access

Livio Pagano, Pier Luigi Zinzani, Stefano Aldo Pileri, Pietro Quaglino, Branko Cuglievan, Emilio Berti, +5 more

25

citations
Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria
2023 HemaSphere article Medicine Telomeres, Telomerase, and Senescence Open access

Mareike Tometten, Martin Kirschner, Robert Meyer, Matthias Begemann, Insa Halfmeyer, Margherita Vieri, +18 more

22

citations
Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force
2022 HemaSphere article Health Professions Healthcare Regulation Open access

Isabel Dombrink, Bart R. Lubbers, Loredana Simulescu, Robin Doeswijk, Olga Yu. Tkachenko, Elisabeth M. C. Dequeker, +5 more

18

citations
P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B-ALL IN ADULTS. A PHASE II HOVON TRIAL
2022 HemaSphere article Medicine Acute Lymphoblastic Leukemia research Open access

A. Rijneveld, Patrycja L. Gradowska, Mar Bellido, Okke de Weerdt, Alain Gadisseur, Dries Deeren, +15 more

17

citations
Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
2021 HemaSphere article Medicine Platelet Disorders and Treatments Open access cited by 1 patent

Johan Boender, Ferdows Atiq, Marjon H. Cnossen, Johanna G. van der Bom, Karin Fijnvandraat, Joke de Meris, +6 more

15

citations
Outcome of 129 Pregnancies in Polycythemia Vera Patients: A Report of the European LeukemiaNET
2023 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Kai Wille, Maja Brouka, Johannes Bernhardt, Axel Rüfer, Emilia Niculescu‐Mizil, Mirjana Gotić, +13 more

14

citations
S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.
2023 HemaSphere article Medicine Chronic Myeloid Leukemia Treatments Open access

Thomas Ernst, Philipp le Coutre, Martina Margrit Crysandt, Tim H. Brümmendorf, Georg‐Nikolaus Franke, Thomas Illmer, +10 more

13

citations
Novel approaches in myelofibrosis
2024 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Steffen Koschmieder

12

citations
Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies
2020 HemaSphere article Medicine Monoclonal and Polyclonal Antibodies Research Open access

Hilma J. van der Horst, Simone C. Oostindie, Saskia A.G.M. Cillessen, Anne T. Gelderloos, Marije B. Overdijk, Inger S. Nijhof, +4 more

12

citations
Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma
2020 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

Anil K. Deshantri, Marcel H.A.M. Fens, Ruud W. J. Ruiter, Josbert M. Metselaar, Gert Storm, Sanjay N. Mandhane, +8 more

11

citations
P1051: A PHASE 2 STUDY OF IMG-7289 (BOMEDEMSTAT) IN PATIENTS WITH ADVANCED MYELOFIBROSIS
2022 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Harinder Gill, Abdulraheem Yacoub, Kristen Marie Pettit, Terrence Bradley, Aaron Thomas Gerds, Maciej Tatarczuch, +30 more

11

citations
S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN PATIENTS WITH HIGH-RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS
2023 HemaSphere article Medicine Lymphoma Diagnosis and Treatment Open access

Anna Sureda, Lorenzo Falchi, Sirpa Leppä, Joost S.P. Vermaat, Harald Holte, Martin Hutchings, +13 more

11

citations
Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B‐Cell Precursor Acute Lymphoblastic Leukemia
2020 HemaSphere article Medicine Acute Lymphoblastic Leukemia research Open access

Jiangyan Yu, Esmé Waanders, Simon V. van Reijmersdal, Željko Antić, Charlotte M. van Bosbeek, Edwin Sonneveld, +7 more

9

citations
S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS
2023 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

Nizar Jacques Bahlis, Katja Christina Weisel, María‐Victoria Mateos, Hartmut Goldschmidt, Tom G. Martin, Daniel Morillo, +14 more

9

citations
P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION.
2022 HemaSphere article Medicine Chronic Myeloid Leukemia Treatments Open access

C. C. Kockerols, Jurriaan Janssen, Nicole M. A. Blijlevens, Saskia K. Klein, L. G. van Hussen-Daenen, Gwendolyn N. Y. van Gorkom, +10 more

8

citations
S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.
2023 HemaSphere article Medicine Chronic Myeloid Leukemia Treatments Open access

Andreas Hochhaus, Andreas Burchert, Susanne Saußele, Gabriela Maria Baerlocher, Jiřı́ Mayer, Tim H. Brümmendorf, +20 more

6

citations

Most active Aachen authors

Tim H. Brümmendorf 16,145 citations overall
18 papers
Jens Panse 10,288 citations overall
14 papers
Steffen Koschmieder 11,677 citations overall
13 papers
Joost S.P. Vermaat 3,482 citations overall
10 papers
Fabian Beier 3,900 citations overall
9 papers
Susanne Isfort 2,466 citations overall
8 papers
Jacques J. M. van Dongen 55,067 citations overall
5 papers
Martina Margrit Crysandt 2,348 citations overall
5 papers
Ivan G. Costa 12,219 citations overall
4 papers
Edgar Jost 3,752 citations overall
4 papers
Deniz Gezer 1,428 citations overall
4 papers
Margherita Vieri 507 citations overall
4 papers
Rafael Kramann 16,535 citations overall
3 papers
James Shiniti Nagai 2,988 citations overall
3 papers
Nicolas Chatain 1,606 citations overall
3 papers

HemaSphere ▲ Sign in to save

Aachen papers per year

Papers 116

Most active Aachen authors

HemaSphere Sign in to save